Dual stimulus of hyperthermia and intracellular redox environment triggered release of siRNA for tumor-specific therapy

被引：22

作者：

Yang, Yanfang ^{[1
,2
,3
]}

Yang, Yang ^{[4
]}

Xie, Xiangyang ^{[5
]}

Xu, Xueqing ^{[1
,2
,3
]}

Xia, Xuejun ^{[1
,2
,3
]}

Wang, Hongliang ^{[1
,2
,3
]}

Li, Lin ^{[1
,2
,3
]}

Dong, Wujun ^{[1
,2
,3
]}

Ma, Panpan ^{[1
,2
,3
]}

Liu, Yuling ^{[1
,2
,3
]}

机构：

[1] Chinese Acad Med Sci, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing 100050, Peoples R China

[2] Peking Union Med Coll, Beijing 100050, Peoples R China

[3] Chinese Acad Med Sci, Inst Mat Med, Beijing Key Lab Drug Delivery Technol & Novel For, Beijing 100050, Peoples R China

[4] Beijing Inst Pharmacol & Toxicol, Beijing 100850, Peoples R China

[5] Guangzhou Mil Command, Wuhan Gen Hosp, Wuhan 430070, Peoples R China

来源：

INTERNATIONAL JOURNAL OF PHARMACEUTICS | 2016年 / 506卷 / 1-2期

基金：

美国国家科学基金会;

关键词：

Dual stimulus; Heat-activable; Intracellular redox environment; Cell-penetrating peptides; Small interfering RNA; TEMPERATURE-SENSITIVE LIPOSOMES; DRUG-DELIVERY; THERMOSENSITIVE LIPOSOMES; SOLID TUMORS; DOXORUBICIN; NANOPARTICLES; ULTRASOUND; CONJUGATE; PEPTIDES; PROTEINS;

D O I：

10.1016/j.ijpharm.2016.04.035

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Small interfering RNA (siRNA) offers a new and potential therapeutic strategy for tackling many diseases at the molecular level. Recently, cell-penetrating peptides (CPPs) conjugated with siRNA via disulfide-bonds (designated as siRNA-CPPs) were reported to form glutathione-sensitive carriers. However, noncell specificity, CPPs degradation and the unwanted reduction of siRNA-CPPs before reaching the targeted tissue in vivo hampered the development of siRNA-CPPs. Herein, utilizing the dual stimulus of hyperthermia and the intracellular redox environment, we devised a thermosensitive liposome (TSL) containing an Asparagine-Glycine-Arginine (NGR) peptide and reducible siRNA-CPPs for tumor-specific siRNA transfection (siRNA-CPPs/NGR-TSL), in which siRNA-CPPs were "caged" in NGR-TSL to overcome their limitations in vivo. The functional nanocarrier possessed a small particle size of approximately 90 nm, a high drug encapsulation efficiency of approximately 86% and good serum stability. Both free siRNA-CPPs and siRNA-CPPs/NGR-TSL (preheated) silenced c-myc in human fibrosarcoma (HT-1080) cells in vitro. However, in an HT-1080 xenograft murine model, siRNA-CPPs/NGR-TSL with hyperthermia displayed superior in vivo antitumor efficacy (about 3-fold) and gene silencing efficiency (about 2-fold) compared with free siRNA-CPPs under hyperthermia. This study demonstrates that the constructed vesicle in combination with hyperthermia could greatly improve the in vivo stability of siRNA-CPPs and synergistically enhance its cancer therapy efficiency. (c) 2016 Elsevier B.V. All rights reserved.

引用

页码：158 / 173

页数：16

共 37 条

[11]

Kong G, 2001, CANCER RES, V61, P3027

[12] Hyperthermia and Thermosensitive Liposomes for Improved Delivery of Chemotherapeutic Drugs to Solid Tumors [J].

Koning, Gerben A. ;

Eggermont, Alexander M. M. ;

Lindner, Lars H. ;

ten Hagen, Timo L. M. .

PHARMACEUTICAL RESEARCH, 2010, 27 (08) :1750-1754

[13] Structural modification of siRNA for efficient gene silencing [J].

Lee, So Jin ;

Son, Sejin ;

Yhee, Ji Young ;

Choi, Kuiwon ;

Kwon, Ick Chan ;

Kim, Sun Hwa ;

Kim, Kwangmeyung .

BIOTECHNOLOGY ADVANCES, 2013, 31 (05) :491-503

[14] Going beyond the liver: Progress and challenges of targeted delivery of siRNA therapeutics [J].

Lorenzer, Cornelia ;

Dirin, Mehrdad ;

Winkler, Anna-Maria ;

Baumann, Volker ;

Winkler, Johannes .

JOURNAL OF CONTROLLED RELEASE, 2015, 203 :1-15

[15] Delivery of short interfering RNA using endosomolytic cell-penetrating peptides [J].

Lundberg, Pontus ;

El-Andaloussi, S. ;

Sutlu, T. ;

Johansson, H. ;

Langel, U. .

FASEB JOURNAL, 2007, 21 (11) :2664-2671

[16] Overcoming Limitations in Nanoparticle Drug Delivery: Triggered, Intravascular Release to Improve Drug Penetration into Tumors [J].

Manzoor, Ashley A. ;

Lindner, Lars H. ;

Landon, Chelsea D. ;

Park, Ji-Young ;

Simnick, Andrew J. ;

Dreher, Matthew R. ;

Das, Shiva ;

Hanna, Gabi ;

Park, Won ;

Chilkoti, Ashutosh ;

Koning, Gerben A. ;

ten Hagen, Timo L. M. ;

Needham, David ;

Dewhirst, Mark W. .

CANCER RESEARCH, 2012, 72 (21) :5566-5575

[17] Non-ionic surfactant vesicles in pulmonary glucocorticoid delivery: Characterization and interaction with human lung fibroblasts [J].

Marianecci, Carlotta ;

Paolino, Donatella ;

Celia, Christian ;

Fresta, Massimo ;

Carafa, Maria ;

Alhaique, Franco .

JOURNAL OF CONTROLLED RELEASE, 2010, 147 (01) :127-135

[18] A novel potent strategy for gene delivery using a single peptide vector as a carrier [J].

Morris, MC ;

Chaloin, L ;

Méry, J ;

Heitz, F ;

Divita, G .

NUCLEIC ACIDS RESEARCH, 1999, 27 (17) :3510-3517

[19] Lung delivery studies using siRNA conjugated to TAT(48-60) and penetratin reveal peptide induced reduction in gene expression and induction of innate immunity [J].

Moschos, Sterghios Athanasios ;

Jones, Simon Wyn ;

Perry, Mark Michael ;

Williams, Andrew Evan ;

Erjefalt, Jonas Sten ;

Turner, John James ;

Barnes, Peter John ;

Sproat, Brian Stephen ;

Gait, Michael John ;

Lindsay, Mark Andrew .

BIOCONJUGATE CHEMISTRY, 2007, 18 (05) :1450-1459

[20] Conjugate for efficient delivery of short interfering RNA (siRNA) into mammalian cells [J].

Muratovska, A ;

Eccles, MR .

FEBS LETTERS, 2004, 558 (1-3) :63-68

← 1 2 3 4 →